nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are we nearer to curing patients with MDS?
|
Sekeres, Mikkael A. |
|
2010 |
23 |
4 |
p. 481-487 7 p. |
artikel |
2 |
Can every patient be mobilized?
|
DiPersio, John F. |
|
2010 |
23 |
4 |
p. 519-523 5 p. |
artikel |
3 |
Dose intensity of preparative regimens for acute myeloid leukemia – One-size-fits-all or tailor-made?
|
Appelbaum, Frederick R. |
|
2010 |
23 |
4 |
p. 509-517 9 p. |
artikel |
4 |
Editorial Board / Aims & Scope
|
|
|
2010 |
23 |
4 |
p. iii- 1 p. |
artikel |
5 |
Epigenetics in AML
|
Melnick, Ari M. |
|
2010 |
23 |
4 |
p. 463-468 6 p. |
artikel |
6 |
Faculty Disclosures
|
|
|
2010 |
23 |
4 |
p. III-IV nvt p. |
artikel |
7 |
Genetic deletions in AML and MDS
|
Ebert, Benjamin L. |
|
2010 |
23 |
4 |
p. 457-461 5 p. |
artikel |
8 |
Has there been progress in the treatment of older patients with acute myeloid leukemia?
|
Erba, Harry P. |
|
2010 |
23 |
4 |
p. 495-501 7 p. |
artikel |
9 |
Have we made progress in the management of chronic graft-vs-host disease?
|
Lee, Stephanie J. |
|
2010 |
23 |
4 |
p. 529-535 7 p. |
artikel |
10 |
How closely related is graft-vs-leukemia to donor/recipient disparity?
|
Weisdorf, Daniel J. |
|
2010 |
23 |
4 |
p. 525-528 4 p. |
artikel |
11 |
Index
|
|
|
2010 |
23 |
4 |
p. I- 1 p. |
artikel |
12 |
Is there a role for differentiating therapy in non-APL AML?
|
Koeffler, H. Phillip |
|
2010 |
23 |
4 |
p. 503-508 6 p. |
artikel |
13 |
New agents in post-remission therapy
|
Stone, Richard M. |
|
2010 |
23 |
4 |
p. 475-479 5 p. |
artikel |
14 |
Targeting DNA repair pathways in AML
|
D’Andrea, Alan D. |
|
2010 |
23 |
4 |
p. 469-473 5 p. |
artikel |
15 |
The evolving paradigm of prognostic factors in AML: Introduction to the Acute Leukemia Forum 2010
|
Rowe, Jacob M. |
|
2010 |
23 |
4 |
p. 453-456 4 p. |
artikel |
16 |
Will newer tyrosine kinase inhibitors have an impact in AML?
|
Levis, Mark J. |
|
2010 |
23 |
4 |
p. 489-494 6 p. |
artikel |